Welcome to NGC. Skip directly to: Search Box, Navigation, Content.
Expert Resources > Expert Commentary
Expert Commentary |
Have Comments? E-mail them to us. |
| Perspective |
Endocarditis Prophylaxis: Re-examining the Evidence
By: Michael W. Rich, MD
The American Heart Association (AHA) first published guidelines for the prevention of bacterial endocarditis in 1955 (1), and from 1957 to 1997, the guidelines were updated eight times. These guidelines have reflected current consensus opinion on the cardiovascular conditions which pose a significant risk for developing endocarditis, the procedures for which the risk of bacteremia is sufficiently high to warrant antibiotic prophylaxis, and the selection of an antibiotic regimen designed to minimize the risk of infection. Over the past 50 years, the guidelines have become widely accepted by clinicians and dentists and have been considered the "standard of care" for appropriately selected patients undergoing dental work and various other invasive procedures. From the beginning, however, the guidelines were based almost exclusively on expert opinion rather than on evidence from clinical studies that confirmed antibiotic prophylaxis is indeed effective in reducing the risk of endocarditis without exposing large numbers of patients to the small but nevertheless very real risk of serious adverse reactions to antibiotics, including anaphylaxis and, rarely, death.
In recent years, the "conventional wisdom" on antibiotic prophylaxis has come under increased scrutiny, and several studies have questioned the value of this intervention. In 2004, for example, a Cochrane review of penicillin for bacterial endocarditis in patients undergoing dental procedures concluded that "there is no evidence about whether penicillin prophylaxis is effective or ineffective against bacterial endocarditis in people at risk who are about to undergo an invasive dental procedure." The authors of the review further stated that "there is a lack of evidence to support published guidelines in this area. It is not clear whether the potential harms and costs of penicillin administration outweigh any beneficial effect." (2)
In light of these growing concerns, in 2007, after a hiatus of 10 years, the AHA released new guidelines for the prevention of infective endocarditis (3). Based on a reassessment of available evidence, the authors of the revised guidelines drew several important conclusions that significantly impacted their recommendations (see Table 1). As a result, the new guidelines represent a major departure from previous recommendations in that both the cardiac conditions warranting prophylaxis (see Table 2) and the procedures for which prophylaxis is recommended (see Table 3) have been markedly restricted. For example, patients with mitral valve prolapse (with or without a heart murmur) no longer require prophylaxis prior to dental procedures, nor do patients undergoing routine diagnostic gastrointestinal or urological procedures, including endoscopy and cystoscopy. As a result, the revised guidelines greatly simplify the "rules" for prophylaxis for primary care physicians, cardiologists, gastroenterologists, urologists and other surgeons, dentists, and, not least importantly, patients themselves.
Early reaction to the revised guidelines has been somewhat mixed. Some clinicians and patients have, understandably, been reluctant to depart from longstanding and presumably authoritative recommendations that have become engrained in the culture of medical practice, and concern has been expressed that failure to provide prophylaxis might expose patients to an undue risk of contracting endocarditis. However, in my estimation, these fears are unfounded since, as noted in the new guidelines, the cumulative risk of endocarditis resulting from bacteremia related to routine daily activities, especially tooth brushing, is substantially higher than the risk associated with dental work and most medical procedures. Thus, it makes more sense to emphasize maintenance of optimal oral health than to provide antibiotic prophylaxis prior to dental procedures. In my view, the new guidelines serve to rectify what in the past has been an overly aggressive use of antibiotic prophylaxis, which has not been shown to reduce the risk of endocarditis or to improve patient outcomes. I therefore strongly support the new guidelines and believe that they should be widely disseminated. Clinicians should be encouraged to rapidly adopt these new recommendations, which really represent more of a "course correction" than a radical change in policy.
Author
Michael W. Rich, MD
St. Louis, MO
Disclaimer
The views and opinions expressed are those of the author and do not necessarily state or reflect those of the National Guideline Clearinghouse™ (NGC), the Agency for Healthcare Research and Quality (AHRQ), or its contractor ECRI Institute.
Potential Conflicts of Interest
Dr. Rich states no conflicts of interest.
References
Table 1
Primary Reasons for Revision of the Infective Endocarditis Prophylaxis Guidelines
Source: Adapted from Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis. Guidelines from the American Heart Association. Circulation 2007;116:1736-54.
Table 2
Cardiac Conditions Associated with the Highest Risk of Adverse Outcome from Endocarditis for Which Prophylaxis with Dental Procedures is Reasonable
*Except for the conditions listed above, antibiotic prophylaxis is no longer recommended for any other form of CHD.
**Prophylaxis is reasonable because endothelialization of prosthetic material occurs within 6 months after the procedure.
Source: Adapted from Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis. Guidelines from the American Heart Association. Circulation 2007;116:1736-54.
Table 3
Procedures for Which Antibiotic Prophylaxis is Reasonable
Procedures for Which Antibiotic Prophylaxis is Not Recommended
Source: Adapted from Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis. Guidelines from the American Heart Association. Circulation 2007;116:1736-54.